ApoE genotype may affect protease inhibitor-associated hyperlipidaemia

被引:0
|
作者
机构
关键词
Public Health; Lipid; Protease Inhibitor; Cardiovascular Risk; Cardiovascular Risk Factor;
D O I
10.2165/00128415-199907590-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [1] ApoE genotype and protease-inhibitor-associated hyperlipidaemia
    Behrens, G
    Schmidt, HHJ
    Stoll, M
    Schmidt, RE
    LANCET, 1999, 354 (9172): : 76 - 76
  • [2] Protease inhibitor-associated hyperinsulinaemia
    Martínez, E
    Casamitjana, R
    Conget, I
    Gatell, JM
    AIDS, 1998, 12 (15) : 2077 - 2079
  • [3] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
    Carr, A
    Samaras, K
    Chisholm, DJ
    Cooper, DA
    LANCET, 1998, 351 (9119): : 1881 - 1883
  • [4] Protease inhibitor-associated hyperglycaemia
    Dube, MP
    Johnson, DL
    Currier, JS
    Leedom, JM
    LANCET, 1997, 350 (9079): : 713 - 714
  • [5] Protease inhibitor-associated angiolipomatosis
    Dank, JP
    Colven, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (01) : 129 - 131
  • [6] Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study
    Baldini, F
    Di Giambenedetto, S
    Cingolani, A
    Murri, R
    Ammassari, A
    De Luca, A
    AIDS, 2000, 14 (11) : 1660 - 1662
  • [7] Management of protease inhibitor-associated hyperlipidemia
    Penzak S.R.
    Chuck S.K.
    American Journal of Cardiovascular Drugs, 2002, 2 (2) : 91 - 106
  • [8] Management of protease inhibitor-associated diarrhea
    Sherman, DS
    Fish, DN
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (06) : 908 - 914
  • [9] Predictors of protease inhibitor-associated adverse events
    Bonfanti, P
    Ricci, E
    Landonio, S
    Valsecchi, L
    Timillero, L
    Faggion, I
    Quirino, T
    BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (06) : 321 - 323
  • [10] Protease Inhibitor-Associated QT Interval Prolongation
    Hunt, Kimberley
    Hughes, Christine A.
    Hills-Nieminen, Cara
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1544 - 1550